Market Indicators
- JSE All Share (ALSI) 76,704.26
- Rand/Euro R 20.43
- Rand/Pound R 23.99
- Rand/US Dollar R 18.84
- Rand/Aus Dollar R 12.51
Would you like fries with that?
In this month’s commentary, we explore the rising success of Novo Nordisk, a century-old Danish pharmaceutical company that has transformed from an insulin manufacturer into a pioneer in the weight loss industry. Notably, Novo Nordisk is a significant holding in the BNY Mellon Long Term Global Equity Fund, managed by Walter Scott & Partners and is included in our global equity portfolios.
